OCuSOFT, an ophthalmic pharmaceutical research, development and supply company has announced an agreement with Young Medical Nutrition to exclusively market and distribute ZYTAZE, OCuSOFT’s botulinum toxin-enhancing, zinc- and phytase-based supplements, to dispensing dermatologists and cosmetic surgeons in North America. “OCuSOFT recognizes that a significant number of our ophthalmic products cross over into dermatology, and we are excited that the Young-OCuSOFT partnership will allow us to expand our reach so that more patients can benefit from the use of ZYTAZE,” said Nat Adkins, chairman of the board of OCuSOFT.
“It is an honor to collaborate with OCuSOFT in expanding the use of ZYTAZE into aesthetic medicine,” added John Kulesza, president of Young, a leading supplier of medical skincare products. “This addition to our current line clearly demonstrates our commitment to physician-dispensed retailing.”
